Syntax Bio, a synthetic biology company programming the next generation of cell therapies, has published new research in ...

Syntax Bio, a synthetic biology company programming the next generation of cell therapies, today announced the publication of new research in Science Advances detailing the company’s CRISPR-based ...

A recombinant laminin matrix from Amsbio has played a key role in a new study from the Stanford University School of Medicine ...

Molecular and morphological profiles of developing neurons in vitro uncover the cellular dynamics of human neurodevelopment and related disease.

Typically, bone marrow research relies heavily on animal models and oversimplified cell cultures in the laboratory. Now, researchers from the Department of Biomedicine at the University of Basel and ...

Scalable iPSC neuron manufacturing advances neuroscience, improving disease modeling, therapeutic development, and clinical readiness.

New research, led by LJI scientists, offers a potential way to boost tissue-resident memory T cell numbers to better fight disease.

Understanding how cells differentiate during early embryonic development is crucial for advancing regenerative medicine and developmental biology. Pluripotent stem cells (PSCs) have been invaluable ...

Natural killer (NK) cells are essential effectors of the innate immune system. These cells exhibit potent anti-tumor capabilities, making them appealing candidates for cancer immunotherapy. While ...